AAAyşegül İsal Arslan

Ayşegül İsal Arslan

*This is an algorithmically generated author record based on publicly available information.

Ayşegül İsal Arslan has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ELF-3 and TSC-1 as potential markers of recurrence in low-risk non–muscle-invasive bladder cancer

    by Enes Altın, Çağrı Doğan, Ayşegül İsal Arslan, Erdem Can Topkaç, Cenk Murat Yazıcı, Rıdvan Özcan, Hacı Murat Akgül, Mehmet Fatih Şahin

    Tumor recurrence is a major clinical challenge in low-risk non-muscle invasive bladder cancer (NMIBC). Molecular studies have identified two main subtypes


  • Examining Surgical Margins in the Excision of Basal Cell Carcinoma and Squamous Cell Carcinoma: Evaluating Pre‐Excision, Post‐Excision, Post‐Fixation, and Pathological Margin Measurements

    by Özgür Agdoğan, Ayşegül İsal Arslan

    Introduction: There remains uncertainty regarding whether the determination of a safe margin is the responsibility of the surgeon or the pathologist during the pathological analysis of tissue from various procedures. This study aims to assess the alterations in surgical margin dimensions of tissue 1 h post‐excision, following 24 h of formalin fixation, and pathological in comparison to the margin determined prior to excision. Patients and Methods: Measurements and mean values were taken for each specimen at four stages: before excision, 1 h post‐excision, after 24 h of 10% formalin fixation, and following pathologic examination. BCCs and SCCs were evaluated independently, and statistical analyses were performed to assess changes in the measurements of the specimens. Results: Table 1 illustrates highly significant reductions of the order of 70%–80% overall in the measured specimen margin widths over time for all of the categories measured. Conclusion: Excised skin cancers were found to undergo significant shrinkage at every stage of pathological evaluation, resulting in a surgical margin significantly narrower than the safety margin initially determined. We have clarified what the surgical margin reported by the dermatopathologist actually means. In this way, it was aimed to eliminate the disagreement between the surgeon and the pathologist and to prevent the need for additional surgery and morbidities.


  • Open Access

    Are fungi and EBV effective in cholesteatoma etiology?

    by Ayşegül İsal Arslan, Sevil Karabağ, Tolga Ersözlü

    Aim: Cholesteatoma is a commonly seen disease whose pathogenesis remains unknown. Although not a neoplastic process, it may progress to a fatal condition with local bone destruction. In this study, we aimed to present new insights concerning the etiology of cholesteatoma triggered by an inflammatory process.Materials and Methods: The study included 34 patients diagnosed with cholesteatoma upon mastoidectomy performed between 2011-2019. Due to a provisional diagnosis of cholesteatoma. The cases were investigated for the latent membrane protein (LMP-1) encoded by the Epstein-Barr Virus (EBV) using the immunohistochemical method and for the presence of fungi using Grocott’s methenamine silver (GMSII) stain.Results: No fungi was detected in any of the 34 patients by GMSII staining. Thirty-two of the 34 patients were negative with but a suspicious result was seen in 2 patients with the immunohistochemical EBV antibody. EBV-encoded RNA (EBER) analysis was applied to these 2 cases with the silver in situ hybridization method and no reaction was observed.Conclusion: In our study, we investigated the presence of fungi and EBV, which can trigger the inflammatory process. However, no EBV or fungi was detected in the tissues. Our study is the first to investigate the presence of EBV and fungi in formalin-fixed tissue in cases of aggressive cholesteatoma.

  • Open Access

    Baş-Boyun Skuamöz Hücreli Karsinomlarında EGFR, P16 ve Ki67 Ekspresyonunun Prognoza Etkisi

    by Sevil Karabağ, Ayşegül İSAL ARSLAN, Tolga Ersözlü

    Objective: HPV and EGFR expression status may be utilized as an independent prognostic factor owing to the different clinical and demographic characteristics head and neck cancers. In the study, it was aimed to investigate the association between EGFR, p16 and ki67 expression and survival in patients with head and neck squamous cell carcinoma (SCC).Materials and Methods: A total of 43 patients with SCC of the head and neck region were included in the study. EGFR, p16 and Ki67 were examined by means of immunohistochemistry. The association between these markers and survival was investigated.Results: EGFR expression was detected in 14 cases (32.5%), Staining with p16 was positive in 20 cases (46.5%). Mean duration of follow up was 32 months. There was a statistically significant difference between ki67 proliferation indices of patients who survived and those who died (p=0.037). Survival was significantly shorter in EGFR positive patients compared to those negative for EGFR expressions (p=0.037). Mean survival was 30 months in the 20 p16 positive patients and 33.5 months in p16 negative patients (p=0.847).Conclusion: This study supports that EGFR and Ki67 may be important markers to predict prognosis and survival in patients with head and neck SCC.

  • Open Access

    The importance of p16 and CD117 expression in melanocytic lesions

    by Sevil Karabağ, Ayşegül İsal Arslan

    Aim: The present study aims to determine the p16 and CD117 expression profiles of melanocytic lesions to investigate immune profiles that may facilitate differential diagnosis of melanoma from benign or potential precursor melanocytic lesions. Materials and Methods: Immunohistochemistry for p16 and CD117 was applied in a total of 81 cases with melanocytic lesions. Results: A significant loss of p16 expression was found in melanoma cases compared to benign and precursor melanocytic lesions (pppppp<0.01). Sonuç: p16 ve CD117 belirteçlerinin birlikte kullanıldığı zaman, melanomları benign lezyonlardan ve benign lezyonları potansiyel prekürsör melanositik lezyonlardan ayırımda önemli belirteçler olarak katkı sağlayacağını düşünmekteyiz.


  • Open Access

    Intraparenchymal Leiomyoma of the Breast: A Rare Location for an Infrequent Tumor

    by Mehmet Tolga Kafadar, Metin Yalcin, Mehmet Ali Gok, Aysegul Aktas, Tacittin Semih Yurekli, Aysegul Isal Arslan

    Eur J Breast Health AVES | Copyright © 2017 Türkiye Meme Hastalıkları Dernekleri Federasyonu |